Genomictree Inc.
228760·KOSDAQ·5 grants
- Shares granted, cumulative
- 598,019shares
- Next lockup release
- —
Against the share price
At the 2026-08-18 close- Shares with a reason to exercise
- 114,009 shares
- 0.46% of shares outstanding
- Sellable right now
- 114,009 shares
- 100% of the shares with a reason to exercise
- Unrealized paper gain (to the employees)
- ₩55.7M
Potential dilution
Shares by strike price
- ₩35,800376K shares
- ₩27,00048K shares
- ₩12,61060K shares
- ₩12,070Latest price
- ₩11,84064K shares
- ₩11,25150K shares
Below the line (strike < Latest price) sits above the strike price: 114K shares, 19% of the shares still inside their exercise window.
Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.
Share price vs. strike price
A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.
- Strike ₩35,800376K shares
- Strike ₩11,84064K sharesabove
- Strike ₩12,61060K shares
- Strike ₩11,25150K sharesabove
Recipients by role
- Unregistered officer3 people14%
- Employee31 people25%
- Other · unknown92 people61%
Sorted from the relation text written in the filings (126 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers. This company reported many recipients under a lumped label such as “executives and employees”, or left the field blank, so the breakdown is limited.
Shares granted by year
Cumulative grants per recipient
16 named · 110 withheld| Recipient | Shares, cumulative | Average strike | Exercisable | Paper gain |
|---|---|---|---|---|
| 60,00013.5% | ₩12,610 | 60,000 | — | |
| 50,00011.3% | ₩11,251 | 50,000 | ₩41M | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — |
Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.
Grant history · lockup schedule
Exercisable shares over time
It rises on the day a lockup ends and falls on the day an exercise window closes. Options actually exercised are not subtracted, because only executives have to report them.
20231 grant · 64,009 shares
- Granted2023-03-29
- Exercise starts2025-03-29
- Exercise ends2032-03-28
- Shares granted
- 64,009shares
- Strike price
- 11,840KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Above the strike price₩230 per share₩14.7MReport on grant of stock options
20221 grant · 50,000 shares
- Granted2022-03-28
- Exercise starts2025-03-28
- Exercise ends2032-03-27
- Shares granted
- 50,000shares
- Strike price
- 11,251KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Above the strike price₩819 per share₩41MReport on grant of stock options
20211 grant · 60,000 shares
- Granted2021-03-30
- Exercise starts2024-03-30
- Exercise ends2031-03-29
- Shares granted
- 60,000shares
- Strike price
- 12,610KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20201 grant · 48,010 shares
- Granted2020-03-24
- Exercise starts2022-03-24
- Exercise ends2027-03-23
- Shares granted
- 48,010shares
- Strike price
- 27,000KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20191 grant · 376,000 shares
- Granted2019-03-26
- Exercise starts2021-03-26
- Exercise ends2029-03-25
- Shares granted
- 376,000shares
- Strike price
- 35,800KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.